8 results match your criteria: "German Institute for Medical Mission[Affiliation]"
Am J Trop Med Hyg
July 2024
Pharmaceutical Institute, Eberhard Karls University Tübingen, Tübingen, Germany.
This study investigated the quality of 13 essential medicines in the states of Enugu and Anambra, Nigeria. A total of 260 samples were purchased from licensed pharmaceutical manufacturers and wholesalers and from vendors in pharmaceutical markets with unclear licensing status. Samples were analyzed for identity, content, and dissolution according to the United States Pharmacopeia (USP) 42 monographs.
View Article and Find Full Text PDFFront Public Health
November 2023
Institute of Tropical Medicine, Travel Medicine and Human Parasitology, Competence Centre for Tropical Medicine Baden-Württemberg, Universitätsklinikum Tübingen, Tübingen, Germany.
Despite of contact restrictions, population mobility remains the main reason for the spread of SARS-CoV-2. The state of Baden-Württemberg (BW), Germany, approved a model study in Tübingen (TÜMOD) to evaluate how mandatory rapid diagnostic tests (RDT) could reduce transmission. Between 16 March and 24 April 2021, approximately 165,000 residents and visitors to the city were screened for SARS CoV-2 infection using Abbott Panbio™ COVID-19 Antigen rapid test device.
View Article and Find Full Text PDFSci Rep
July 2022
Pharmaceutical Institute, Eberhard Karls University Tuebingen, Tuebingen, Germany.
This study evaluates the use of the Global Pharma Health Fund (GPHF) Minilab for medicine quality screening by 16 faith-based drug supply organizations located in 13 low- and middle-income countries. The study period included the year before the COVID-19 pandemic (2019) and the first year of the pandemic (2020). In total 1,919 medicine samples were screened using the GPHF Minilab, and samples showing serious quality deficiencies were subjected to compendial analysis in fully equipped laboratories.
View Article and Find Full Text PDFPLoS One
October 2017
Pharmaceutical Institute, Eberhard Karls-University Tübingen, Tübingen, Germany.
Background: Substandard and falsified medical products present a serious threat to public health, especially in low- and middle-income countries. Their identification using pharmacopeial analysis is expensive and requires sophisticated equipment and highly trained personnel. Simple, low-cost technologies are required in addition to full pharmacopeial analysis in order to accomplish widespread routine surveillance for poor-quality medicines in low- and middle-income countries.
View Article and Find Full Text PDFTrans R Soc Trop Med Hyg
May 2004
German Institute for Medical Mission, P.O. Box 1307, 72003 Tübingen, Germany.
The Chinese medicinal plant Artemisia annua L. (Annual Wormwood) contains the antimalarial compound artemisinin. The locally grown herb may offer an additional tool for the control of malaria, especially in poor countries where modern antimalarial drugs are often unavailable.
View Article and Find Full Text PDFMed Health Care Philos
October 2002
Department for Health Policy and Studies, German Institute for Medical Mission, Tübingen.
Inequities in health and health care are one of the greatest challenges facing the international community today. This problem raises serious questions for health care planners, politicians and ethicists alike. The major world religions can play an important role in this discussion.
View Article and Find Full Text PDF